gip and glp-1 receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes Targeting GLP-1, GIP & GCG
Description
Pappas, T

Based on SURMOUNT-1 data analysis, tirzepatide decreased the 10-year estimated risk of ASCVD for obese or overweight patients
Some plans cover these medications but only for patients with specific comorbidities like diabetes, heart disease, or sleep apnea

How does the retatrutide starting dose affect blood sugar

Some people use it online because retatrutide targets three pathways

Contrave (naltrexone/bupropion): A combination medication targeting appetite and cravings